About this trial
This study aims to compare the effectiveness of supervised Schroth exercises versus a home-based exercise program in adolescents with Adolescent Idiopathic Scoliosis (AIS).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of Adolescent Idiopathic Scoliosis (idiopathic etiology)
Age between 10 and 18 years
Cobb angle between 10° and 45°
Able to participate in a 5-day/week exercise program (supervised or home-based)
Disqualifiers
Non-idiopathic scoliosis (neuromuscular, congenital, functional, etc.)
Prior or planned spinal surgery
Neurological, rheumatological, metabolic, or cardiopulmonary disease that would interfere with participation
Brace treatment within the last 6 months or planned during the study
Trial design
Parallel
Treatments tested in this trial
Supervised Schroth Exercise
Other intervention60-minute Schroth exercise sessions, 5 days/week for 12 weeks, delivered under one-on-one physiotherapist supervision. Includes 3D auto-correction, rotational breathing, postural stabilization, and curve-specific exercises (shoulder counter-pull, muscle cylinder, side-lying, sailing, prominent hip, Schroth walking)
Home-Based Schroth Exercise
Other interventionSame 60-minute Schroth exercise program, 5 days/week for 12 weeks, performed at home without direct physiotherapist supervision. Participants receive initial instruction and an individualized exercise booklet.
Treatment groups
Trial outcomes
Primary outcomes
Change in Cobb Angle
Change in the primary curve Cobb angle measured on standing posteroanterior full-spine radiographs, assessed at baseline and 3 months post-intervention.
Secondary outcomes
Change in Trunk Rotation Angle (ATR)
Change in angle of trunk rotation measured using a scoliometer during the Adam's Forward Bend Test.
Change in Thoracic Kyphosis
Change in thoracic kyphosis angle measured using an inclinometer at T1-T2 and T12-L1 levels.
Change in Lumbar Lordosis
Change in lumbar lordosis angle measured using an inclinometer at T12-L1 and S2-S3 levels.
Respiratory Function assessed by Spirometry (FVC, FEV1, FEV1/FVC, PEF, FEF25-75%)
Respiratory function will be assessed using a spirometry device. The following parameters will be recorded and analyzed: Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), the FEV1/FVC ratio, Peak Expiratory Flow (PEF), and Forced Expiratory Flow at 25-75% of FVC (FEF25-75%).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.